共 18 条
- [1] Global variations in lung cancer incidence by histological subtype in 2020: a population-based study [J]. LANCET ONCOLOGY, 2023, 24 (11): : 1206 - 1218
- [2] The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma .[J].Gao Hong;Yang Jun;He Lu;Wang Wei;Liu Yanhong;Hu Yue;Ge Meiling;Ding Jie;Ye Qing.Frontiers in Oncology.2022,
- [3] Detection of short stature homeobox 2 and RAS-associated domain family 1 subtype A DNA methylation in interventional pulmonology..[J].Wu Jian;Li Peng.World journal of clinical cases.2021, 20
- [4] Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma.[J].Li Nanhong;Zeng Yu;Tai Min;Lin Biyun;Zhu Di;Luo Yi;Ren Xinle;Zhu Xiaoying;Li Lanlan;Wu Hongrong;Huang Jian.Frontiers in Molecular Biosciences.2021,
- [5] Adenocarcinoma Spectrum Lesions of the Lung: Detection; Pathology and Treatment Strategies.[J].Succony L;Rassl DM;Barker AP;McCaughan FM;Rintoul RC.Cancer Treatment Reviews.2021, prepublish
- [9] Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.[J].Qinfang Deng;Bo Su;Xianxiu Ji;Qiyu Fang;Songwen Zhou;Caicun Zhou.Cancer Biomarkers.2019, 3